Former PWHL goalie brings women’s health to forefront after cancer diagnosis - CTV News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.

ADVERTISEMENTWatchThough she helped raise the profile of women’s hockey, it’s Erica Howe’s battle after retirement that showed what she’s truly made of. Mike Walker reports. October 06, 2026 at 12:31a.m. EDT
This article is an excerpt. To read the full content, visit the original source. CTV News
Related articles

Former PWHL goalie brings women’s health to forefront after cancer diagnosis - CP24
ADVERTISEMENTWatchThough she helped raise the profile of women’s hockey, it’s Erica Howe’s battle after retirement that showed what she’s truly made of. Mike Walker reports. October 06, 2026 at 12:31a.m. EDT

Women’s hockey is on the rise in Canada. Now the PWHL wants to focus on Women’s health - CP24
ADVERTISEMENTVideoThe PWHL has made tremendous strides raising the profile of women's hockey, and now the league has undertaken a new partnership to also shine a light on women's health. Mike Walker reports. October 05, 2026 at 7:00p.m. EDT

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!